Company page

Vertex Pharmaceuticals Incorporated

Vertex Pharmaceuticals Incorporated, trading under the ticker VRTX, is a prominent public company in the American market. With a market capitalization of approximately $112.9 billion, Vertex focuses on developing innovative therapies for serious diseases. The company is recognized for its commitment to advancing healthcare through research and development.